A point mutation in CD28 distinguishes proliferative signals from survival signals

K Okkenhaug, L Wu, KM Garza, J La Rose… - Nature …, 2001 - nature.com
K Okkenhaug, L Wu, KM Garza, J La Rose, W Khoo, B Odermatt, TW Mak, PS Ohashi
Nature immunology, 2001nature.com
Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One
tyrosine in particular (Y 170 in mouse CD28, Y 173 in human CD28) has received much
attention. This is because it permits CD28 to recruit SH2-containing signaling molecules,
including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic
approach to express a tyrosine→ phenylalanine mutant form of CD28 that uncouples these
SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate …
Abstract
Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y 170 in mouse CD28, Y 173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine→ phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-x L, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.
nature.com